Jan 29, 2020
VGXI to Manufacture Vaccine Against Novel Coronavirus Under CEPI Funded Collaboration
Jan 15, 2020
Warts and Peace: How to Serenely Deal with These Common Skin Growths
Jan 15, 2020
Inovio Welcomes Biotech Leader to its Board of Directors
Jan 14, 2020
ASKA Pharmaceutical Co., Ltd. and KinoPharma, Inc. Enter into Option Agreement for Treatment of Cervical Dysplasia
Jan 06, 2020
Inovio Provides Update on Clinical Program Plans for 2020
Nov 25, 2019
Inovio Pharmaceuticals to Present at the 2019 Piper Jaffray 31st Annual Healthcare Conference
Nov 15, 2019
Inovio Pharmaceuticals to Present at the Stifel 2019 Healthcare Conference
Nov 12, 2019
BD Submits Pre-Market Approval Supplement to FDA for BD Onclarity(TM) HPV Test with Extended Genotyping Capabilities
Nov 07, 2019
Civis Analytics Kicks off "Voice of the Patient" Research Series with New Studies on Telehealth and HPV Vaccination
Oct 29, 2019
Inovio Pharmaceuticals to Report Third Quarter 2019 Financial Results on November 12, 2019
Oct 14, 2019
ISA Pharmaceuticals B.V. Receives EUR 20m Loan From European Investment Bank
Sep 18, 2019
If you could get a vaccination that would prevent cancer - would you?
Sep 18, 2019
HPV Associated Disorders Market Size Worth $23.2 Billion By 2026: Grand View Research, Inc.
Sep 03, 2019
Inovio Pharmaceuticals to Present at Upcoming Investor Conferences
Aug 22, 2019
Global Cervical Cancer Vaccines Market to Surpass US$ 6 Billion by 2026
Aug 19, 2019
Inovio Completes Enrollment of its VGX-3100 Open-label Phase 2 Trial for Treatment of HPV-Related High-Grade Anal Dysplasia
Aug 08, 2019
Inovio Pharmaceuticals Reports 2019 Second Quarter Financial Results
Aug 05, 2019
The global sexually transmitted disease testing market at a CAGR of almost 9% during the forecast period
Jul 30, 2019
Inovio Pharmaceuticals to Report Second Quarter 2019 Financial Results on August 8, 2019
Jul 08, 2019
Inovio Completes Enrollment of VGX-3100 Phase 2 Trial for the Treatment of HPV-Related Vulvar Dysplasia (VIN)